Llp Abingworth's Net Worth

$546 Million

Estimate Recalculated Feb 27, 2024 04:21PM EST

Who is Llp Abingworth?

Llp Abingworth has an estimated net worth of $546 Million. This is based on reported shares across multiple companies, which include Vaxcyte, Inc., AMARIN CORP PLC\UK, Vera Therapeutics, Inc., Sierra Oncology, Inc., Personalis, Inc., Sientra, Inc., Jasper Therapeutics, Inc., SOLENO THERAPEUTICS INC, eFFECTOR Therapeutics, Inc., PROTEON THERAPEUTICS INC, and CHIASMA, INC.

SEC CIK

Llp Abingworth's CIK is 0001397144

Past Insider Trading and Trends

2019 was Llp Abingworth's most active year for acquiring shares with 6 total transactions. Llp Abingworth's most active month to acquire stocks was the month of May. 2020 was Llp Abingworth's most active year for disposing of shares, totalling 9 transactions. Llp Abingworth's most active month to dispose stocks was the month of September. 2014 saw Llp Abingworth paying a total of $16,925,000.00 for 2,512,872 shares, this is the most they've acquired in one year. In 2011 Llp Abingworth cashed out on 9,104,174 shares for a total of $99,463,134.05, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Vaxcyte, Inc. (PCVX) Snapshot price: $74.83

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
0
0
Jun 11
Form 4
0
0
Jun 11
Form 3
0
0
No matching records found

AMARIN CORP PLC\UK (AMRN) Snapshot price: $1.195

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
-71.48%
-4.01M
$9.62
-$38,546,133.87
1.6M
Apr 17 - Apr 19
Form 4
-71.48%
-4.01M
$9.62
-$38,546,133.87
1.6M
Apr 17 - Apr 19
Form 4
-29.09%
-2.30M
$11.00
-$25,300,000.00
5.61M
Apr 3
Form 4
+0.15%
11.68K
7.91M
Dec 20
Form 3
0
0
Form 4
-34.61%
-4.18M
$14.87
-$62,143,481.55
7.9M
Scheduled
Apr 18
Form 4
-18.55%
-2.75M
$7.50
-$20,636,000.00
12.07M
Mar 11
Form 4
-3.58%
-550.00K
$7.50
-$4,125,990.00
14.82M
Mar 8
Form 4
-0.65%
-100.00K
$7.60
-$760,000.00
15.38M
Mar 4
Form 4
-7.20%
-1.20M
$7.70
-$9,239,040.00
15.47M
Mar 2
Form 4
-1.91%
-325.00K
$7.87
-$2,558,622.50
16.68M
Feb 28 - Mar 1
Form 3
0
0
Form 3
0
0
No matching records found

Vera Therapeutics, Inc. (VERA) Snapshot price: $37.9999

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
$15.63
-$91,851.11
2.96M
Aug 17
Form 4
2.96M
$11.00
2.96M
May 13 - May 18
Form 3
0
0
No matching records found

Sierra Oncology, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+49.90%
437.47K
$17.93
$7,844,617.20
1.31M
Jan 28 - Jan 31
Form 3
0
0
No matching records found

Personalis, Inc. (PSNL) Snapshot price: $1.1691

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.36%
-130.49K
$27.66
-$3,609,242.76
3.75M
Oct 20
Form 4
-6.96%
-290.64K
$27.48
-$7,986,081.02
3.88M
Oct 16 - Oct 19
Form 4
-2.01%
-85.63K
$27.05
-$2,315,913.00
4.17M
Oct 14 - Oct 15
Form 4
-4.53%
-202.36K
$28.81
-$5,829,351.86
4.26M
Oct 12 - Oct 13
Form 4
-18.11%
-986.84K
$19.00
-$18,749,998.00
4.46M
Aug 18
Form 4
+2,788.68%
5.26M
5.45M
Jun 24
Form 3
0
0
No matching records found